NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
General Intensive Care Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
WIREs Mech Dis. 2022 Nov;14(6):e1577. doi: 10.1002/wsbm.1577. Epub 2022 Jul 14.
Since the declaration of the novel SARS-CoV-2 virus pandemic, health systems/ health-care-workers globally have been overwhelmed by a vast number of COVID-19 related hospitalizations and intensive care unit (ICU) admissions. During the early stages of the pandemic, the lack of formalized evidence-based guidelines in all aspects of patient management was a significant challenge. Coupled with a lack of effective pharmacotherapies resulted in unsatisfactory outcomes in ICU patients. The anticipated increment in ICU surge capacity was staggering, with almost every ICU worldwide being advised to increase their capacity to allow adequate care provision in response to multiple waves of the pandemic. This increase in surge capacity required advanced planning and reassessments at every stage, taking advantage of experienced gained in combination with emerging evidence. In University Hospital Southampton General Intensive Care Unit (GICU), despite the initial lack of national and international guidance, we enhanced our ICU capacity and developed local guidance on all aspects of care to address the rapid demand from the increasing COVID-19 admissions. The main element of this success was a multidisciplinary team approach intertwined with equipment and infrastructural reorganization. This narrative review provides an insight into the approach adopted by our center to manage patients with COVID-19 critical illness, exploring the initial planning process, including contingency preparations to accommodate (360% capacity increment) and adaptation of our management pathways as more evidence emerged throughout the pandemic to provide the most appropriate levels of care to our patients. We hope our experience will benefit other intensive care units worldwide. This article is categorized under: Infectious Diseases > Genetics/Genomics/Epigenetics.
自新型 SARS-CoV-2 病毒大流行宣布以来, 全球卫生系统/医护人员面临着大量与 COVID-19 相关的住院和重症监护病房 (ICU) 入院患者。在大流行的早期阶段,在患者管理的各个方面缺乏正式的循证指南是一个重大挑战。再加上缺乏有效的药物治疗,导致 ICU 患者的结局不理想。预计 ICU 增量能力的增长是惊人的,几乎全球每个 ICU 都被建议增加其容量,以在应对多波大流行时提供足够的护理。这种增量能力的增加需要在每个阶段进行先进的规划和重新评估,利用所获得的经验和新兴证据。在南安普顿大学医院综合 ICU,尽管最初缺乏国家和国际指南,我们还是提高了 ICU 容量,并就护理的各个方面制定了本地指南,以满足 COVID-19 患者不断增加的需求。这一成功的主要因素是多学科团队的方法,与设备和基础设施的重组交织在一起。本叙述性综述深入探讨了我们中心管理 COVID-19 危重病患者的方法,探讨了初始规划过程,包括应急准备以适应(360%的容量增加),以及随着大流行期间出现更多证据,调整我们的管理途径,为患者提供最合适的护理水平。我们希望我们的经验将使全球其他重症监护病房受益。本文属于以下类别:传染病 > 遗传学/基因组学/表观遗传学。